Browse by People

Collapse authors list.
Casara, Patrick, Davidson, James, Claperon, Audrey, Le Toumelin-Braizat, Gaëtane, Vogler, Meike ORCID: 0000-0003-2650-586X, Bruno, Alain, Chanrion, Maïa, Lysiak-Auvity, Gaëlle, Le Diguarher, Thierry, Starck, Jérôme-Benoît et al (show 28 more authors) , Chen, Ijen ORCID: 0000-0001-8865-3193, Whitehead, Neil, Graham, Christopher, Matassova, Natalia, Dokurno, Pawel ORCID: 0000-0002-7332-8889, Pedder, Christopher, Wang, Youzhen, Qiu, Shumei, Girard, Anne-Marie, Schneider, Emilie, Gravé, Fabienne, Studeny, Aurélie, Guasconi, Ghislaine, Rocchetti, Francesca, Maïga, Sophie, Henlin, Jean-Michel, Colland, Frédéric, Kraus-Berthier, Laurence, Le Gouill, Steven ORCID: 0000-0001-9840-2128, Dyer, Martin JS ORCID: 0000-0002-5033-2236, Hubbard, Roderick, Wood, Mike, Amiot, Martine, Cohen, Gerald M, Hickman, John A, Morris, Erick ORCID: 0000-0002-3566-5630, Murray, James and Geneste, Olivier (2018) S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth. Oncotarget, 9 (28). pp. 20075-20088.

Collapse authors list.
Padidar, Sara ORCID: 0000-0003-2769-210X, Monadjem, Ara, Litschka-Koen, Thea, Thomas, Brent, Shongwe, Nondusimo, Baker, Clare, Mmema, Lindelwa, Sithole, Trevor, Murray, James, Casewell, Nicholas R et al (show 5 more authors) , Pons, Jonathan, Lalloo, David G ORCID: 0000-0001-7680-2200, Harrison, Robert A, Stienstra, Ymkje and Dlamini, Wisdom M (2023) Snakebite epidemiology, outcomes and multi-cluster risk modelling in Eswatini. PLoS neglected tropical diseases, 17 (11). e0011732-.

Collapse authors list.
Menzies, Stefanie K ORCID: 0000-0002-9273-9296, Litschka-Koen, Thea, Edge, Rebecca J, Alsolaiss, Jaffer, Crittenden, Edouard, Hall, Steven R, Westhorpe, Adam, Thomas, Brent, Murray, James, Shongwe, Nondusimo et al (show 5 more authors) , Padidar, Sara, Lalloo, David G ORCID: 0000-0001-7680-2200, Casewell, Nicholas R, Pons, Jonathan and Harrison, Robert A (2022) Two snakebite antivenoms have potential to reduce Eswatini's dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testing. PLOS NEGLECTED TROPICAL DISEASES, 16 (9). e0010496-.